Miller SD - Search Results

1

ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis.

Qian Y, Arellano G, Ifergan I, Lin J, Snowden C, Kim T, Thomas JJ, Law C, Guan T, Balabanov RD, Kaech SM, Miller SD, Choi J. Qian Y, et al. Among authors: miller sd. Cell Rep. 2021 Aug 24;36(8):109602. doi: 10.1016/j.celrep.2021.109602. Cell Rep. 2021. PMID: 34433042 Free PMC article.

2

Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.

Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD. Begolka WS, et al. Among authors: miller sd. J Immunol. 1998 Oct 15;161(8):4437-46. J Immunol. 1998. PMID: 9780223

3

Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.

Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD. Howard LM, et al. Among authors: miller sd. J Clin Invest. 1999 Jan;103(2):281-90. doi: 10.1172/JCI5388. J Clin Invest. 1999. PMID: 9916140 Free PMC article.

4

Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities.

Smith CE, Miller SD. Smith CE, et al. Among authors: miller sd. J Autoimmun. 2006 Dec;27(4):218-31. doi: 10.1016/j.jaut.2006.12.002. J Autoimmun. 2006. PMID: 17289470 Free PMC article.

5

Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis.

Balabanov R, Strand K, Goswami R, McMahon E, Begolka W, Miller SD, Popko B. Balabanov R, et al. Among authors: miller sd. J Neurosci. 2007 Feb 21;27(8):2013-24. doi: 10.1523/JNEUROSCI.4689-06.2007. J Neurosci. 2007. PMID: 17314297 Free PMC article.

6

Astrocytes in multiple sclerosis: a product of their environment.

Nair A, Frederick TJ, Miller SD. Nair A, et al. Among authors: miller sd. Cell Mol Life Sci. 2008 Sep;65(17):2702-20. doi: 10.1007/s00018-008-8059-5. Cell Mol Life Sci. 2008. PMID: 18516496 Free PMC article. Review.

7

Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.

Turley DM, Miller SD. Turley DM, et al. Among authors: miller sd. Results Probl Cell Differ. 2010;51:217-35. doi: 10.1007/400_2008_13. Results Probl Cell Differ. 2010. PMID: 19130025 Free PMC article. Review.

8

The role of antigen presenting cells in multiple sclerosis.

Chastain EM, Duncan DS, Rodgers JM, Miller SD. Chastain EM, et al. Among authors: miller sd. Biochim Biophys Acta. 2011 Feb;1812(2):265-74. doi: 10.1016/j.bbadis.2010.07.008. Epub 2010 Jul 15. Biochim Biophys Acta. 2011. PMID: 20637861 Free PMC article. Review.

9

Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.

Chang RA, Miller SD, Longnecker R. Chang RA, et al. Among authors: miller sd. Sci Rep. 2012;2:353. doi: 10.1038/srep00353. Epub 2012 Apr 3. Sci Rep. 2012. PMID: 22616025 Free PMC article.

10

Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

McCarthy DP, Richards MH, Miller SD. McCarthy DP, et al. Among authors: miller sd. Methods Mol Biol. 2012;900:381-401. doi: 10.1007/978-1-60761-720-4_19. Methods Mol Biol. 2012. PMID: 22933080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters